WebARTIDIS AG 2024–Heute5 Jahre Basel Area, Switzerland Project Lead - Clinical Technology Integration Platform University Hospital Basel, University of Basel 2024–2024weniger als ein Jahr Basel... WebBasel, Switzerland, December 5th, 2024 – ARTIDIS AG (“ARTIDIS”), a privately held healthtech company, announced today the successful closure of a CHF 8.8 million seed financing in two rounds securing early clinical validation and the next development phase towards market entry in 2024.

ARTIDIS First Prospective Study, "NANO”, Evaluating its

WebGitika Srivastava (ARTIDIS AG, Switzerland) "Nanomechanical Signature of Low Dose Radiation-induced Tumor Stroma Remodulation Mediates Tumor Response in Lung Adenocarcinoma" 10:10 am - 10:15 am: Discussion. 10:15 am - 10:25 am: Ye Zhang (Koch Institute for Integrative Cancer Research at MIT, United States) WebARTIDIS enables professionals to design personalized cancer treatment plans tailored to the individual patient needs and desired outcomes. VentureRadar Research / Company … cheap lovesac covers

Leadership team and core values ARTIDIS

Web22 giu 2024 · ARTIDIS AG is a clinical stage health-tech company located in Basel, Switzerland, that has developed the first nanomechanical biomarker for cancer diagnosis … WebARTIDIS AG, founded in Basel, is a clinical stage medical technology company developing the first nanotechnology platform for tissue analysis combined with digital data platform, intended for broad use in drug discovery, tissue engineering as well as for rapid diagnostics and personalized treatment optimization. WebI work for ARTIDIS because I want to help our ARTIDIS technology see the light of day and unfold its life-improving potential for patients. Despite it being a long and demanding journey to get there, I come to work each day because our team inspires me to challenge myself and, most importantly, makes me believe that we can achieve it. cyber liability travelers